National utilization of regional lymph node dissection among patients with kidney cancer and clinical lymphadenopathy undergoing radical nephrectomy

Cancer Treatment and Research Communications - Tập 12 - Trang 14-18 - 2017
Robert Abouassaly1,2, Matthew J. Bream1, Marc C. Smaldone3, Alexander Kutikov3, Nilay D. Shah4, Christopher M. Gonzalez1, Stephen B. Williams5, Robert Houston Thompson6, Stephen A. Boorjian6, Simon P. Kim1,2,7
1University Hospitals Cleveland Medical Center, Case Western Reserve University, Urology Institute, Cleveland, OH, United States
2University Hospitals Cleveland Medical Center, Center for Health Care Quality and Outcomes, Cleveland, OH, United States
3Fox Chase Cancer Center, Department of Surgical Oncology, Philadelphia, PA, United States
4Mayo Clinic, Division of Health Care Policy and Research, Rochester, MN, United States
5University of Texas Medical Branch at Galveston, Texas, Division of Urology, Galveston, TX, United States
6Mayo Clinic, Department of Urology, Rochester, MN, United States
7Yale University, Cancer Outcomes and Public Policy Effectiveness Research Center, Yale University, New Haven, CT, United States

Tài liệu tham khảo

Siegel, 2016, Cancer statistics, 2016, CA Cancer J. Clin., 66, 7, 10.3322/caac.21332 Kane, 2008, Renal cell cancer stage migration: analysis of the national cancer data base, Cancer, 113, 78, 10.1002/cncr.23518 Kim, 2012, Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma, Cancer, 118, 4412, 10.1002/cncr.26695 Motzer, 2015, Kidney cancer, version 3.2015, J. Natl. Compr. Cancer Network, 13, 151, 10.6004/jnccn.2015.0022 Haas, 2016, Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial, Lancet, 387, 2008, 10.1016/S0140-6736(16)00559-6 Pal, 2014, Adjuvant therapy for renal cell carcinoma: past, present, and future, Oncologist, 19, 851, 10.1634/theoncologist.2014-0105 Blute, 2004, A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma, J. Urol., 172, 465, 10.1097/01.ju.0000129815.91927.85 Crispen, 2011, Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates, Eur. Urol., 59, 18, 10.1016/j.eururo.2010.08.042 Pantuck, 2003, Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection, J. Urol., 169, 2076, 10.1097/01.ju.0000066130.27119.1c Whitson, 2011, Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases, J. Urol., 185, 1615, 10.1016/j.juro.2010.12.053 Terrone, 2003, The number of lymph nodes examined and staging accuracy in renal cell carcinoma, BJU Int., 91, 37, 10.1046/j.1464-410X.2003.04017.x Blom, 2009, Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881, Eur. Urol., 55, 28, 10.1016/j.eururo.2008.09.052 Donat, 2013, Follow-up for clinically localized renal neoplasms: AUA guideline, J. Urol., 190, 407, 10.1016/j.juro.2013.04.121 Winchester, 2004, The national cancer data base: a clinical surveillance and quality improvement tool, J. Surg. Oncol., 85, 1, 10.1002/jso.10320 Stata 14 MP. College Station, Texas. Birkmeyer, 2002, Hospital volume and surgical mortality in the United States, New Engl. J. Med., 346, 1128, 10.1056/NEJMsa012337 Couapel, 2014, Is there a volume-outcome relationship for partial nephrectomy?, World J. Urol., 32, 1323, 10.1007/s00345-013-1213-1 Joudi, 2005, The impact of provider volume on outcomes from urological cancer therapy, J. Urol., 174, 432, 10.1097/01.ju.0000165340.53381.48 Kim, 2012, Contemporary trends of in-hospital complications and mortality for radical cystectomy, BJU Int., 110, 1163, 10.1111/j.1464-410X.2012.10990.x Kardos, 2014, Association of type of renal surgery and access to robotic technology for kidney cancer: results from a population-based cohort, BJU Int., 114, 549, 10.1111/bju.12711 Wang, 2015, Association between surgeon and hospital characteristics and lymph node counts from radical prostatectomy and pelvic lymph node dissection, Urology, 85, 890, 10.1016/j.urology.2015.01.006 Marshall, 2013, Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC), BJU Int., 111, 1075, 10.1111/j.1464-410X.2012.11583.x Ku, 2015, Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis, BMC Cancer, 15, 447, 10.1186/s12885-015-1448-x Siemens, 2015, Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: a population-based study, Urol. Oncol., 33, e15 Kim, 2013, The relationship of postoperative complications with in-hospital outcomes and costs after renal surgery for kidney cancer, BJU Int., 111, 580, 10.1111/j.1464-410X.2012.11122.x Aboumarzouk, 2012, Robotic versus laparoscopic partial nephrectomy: a systematic review and meta-analysis, Eur. Urol., 62, 1023, 10.1016/j.eururo.2012.06.038 Chandra, 2015, Robot-assisted surgery for kidney cancer increased access to a procedure that can reduce mortality and renal failure, Health Aff., 34, 220, 10.1377/hlthaff.2014.0986 Wu, 2014, Robotic versus open partial nephrectomy: a systematic review and meta-analysis, PloS One, 9, e94878, 10.1371/journal.pone.0094878 Wang, 2015, Variation in pelvic lymph node dissection among patients undergoing radical prostatectomy by hospital characteristics and surgical approach: results from the national cancer database, J. Urol., 193, 820, 10.1016/j.juro.2014.09.019 Abaza, 2012, Quality of lymphadenectomy is equivalent with robotic and open cystectomy using an extended template, J. Urol., 187, 1200, 10.1016/j.juro.2011.11.092